Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

491 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Towards a comprehensive tobacco-cessation approach: A pilot-training using simulation based-learning among medical students in Türkiye.
Karadoğan D, Ardıç C, Telatar TG, Kanbay Y, Kayaalp E, Dedecan MA, Puşuroğlu M, Özyurt S, Özçelik N, Kara BY, Emlek N, Topçu A, Saral S, Uzun K, Konyalıhatipoğlu EB, Madran EK, Kavak İ, Göksun H, Şahin Ü, Ravara SB. Karadoğan D, et al. Among authors: sahin u. Tob Induc Dis. 2023 Sep 25;21:118. doi: 10.18332/tid/170278. eCollection 2023. Tob Induc Dis. 2023. PMID: 37753195 Free PMC article. No abstract available.
Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study.
Schettini F, Saracchini S, Bassini A, Marus W, Corsetti S, Specogna I, Bertola M, Micheli E, Wirtz RM, Laible M, Şahin U, Strina C, Milani M, Aguggini S, Tancredi R, Fiorio E, Sulfaro S, Generali D. Schettini F, et al. Among authors: sahin u. Breast. 2024 May 25;76:103753. doi: 10.1016/j.breast.2024.103753. Online ahead of print. Breast. 2024. PMID: 38815444 Free article.
Effect of anti-claudin 18.2 monoclonal antibody zolbetuximab alone or combined with chemotherapy or programmed cell death-1 blockade in syngeneic and xenograft gastric cancer models.
Nishibata T, Weng J, Omori K, Sato Y, Nakazawa T, Suzuki T, Yamada T, Nakajo I, Kinugasa F, Türeci Ö, Şahin U, Yoshida T. Nishibata T, et al. Among authors: sahin u. J Pharmacol Sci. 2024 Jul;155(3):84-93. doi: 10.1016/j.jphs.2024.04.004. Epub 2024 Apr 18. J Pharmacol Sci. 2024. PMID: 38797537 Free article.
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell-engaging bispecific antibody targeting human claudin 6.
Stadler CR, Ellinghaus U, Fischer L, Bähr-Mahmud H, Rao M, Lindemann C, Chaturvedi A, Scharf C, Biermann I, Hebich B, Malz A, Beresin G, Falck G, Häcker A, Houben A, Erdeljan M, Wolf K, Kullmann M, Chang P, Türeci Ö, Şahin U. Stadler CR, et al. Among authors: sahin u. Sci Transl Med. 2024 May 22;16(748):eadl2720. doi: 10.1126/scitranslmed.adl2720. Epub 2024 May 22. Sci Transl Med. 2024. PMID: 38776391
Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer.
De Sanctis F, Dusi S, Caligola S, Anselmi C, Petrova V, Rossi B, Angelini G, Erdeljan M, Wöll S, Schlitter AM, Metzler T, Steiger K, Borok Z, Bailey P, Bauer A, Halin C, Boschi F, Giugno R, Canè S, Lawlor R, Corbo V, Scarpa A, Constantin G, Ugel S, Vascotto F, Sahin U, Türeci Ö, Bronte V. De Sanctis F, et al. Among authors: sahin u. Immunity. 2024 May 10:S1074-7613(24)00226-7. doi: 10.1016/j.immuni.2024.04.021. Online ahead of print. Immunity. 2024. PMID: 38749447 Free article.
Effect of Laurus nobilis on bacteria and human transforming growth factor-β1.
Sancer O, Şahin U, Çetin ES, Tepebaşi MY, Cezaroğlu Y, Bilir G, Yünlü S, Koca A. Sancer O, et al. Among authors: sahin u. Rev Assoc Med Bras (1992). 2024 Apr 22;70(3):e20230683. doi: 10.1590/1806-9282.20230683. eCollection 2024. Rev Assoc Med Bras (1992). 2024. PMID: 38655992 Free PMC article.
491 results